デフォルト表紙
市場調査レポート
商品コード
1630646

動物用免疫診断薬市場規模、シェア、成長分析、製品別、技術別、動物の種類別、疾患タイプ別、エンドユーザー別、地域別 - 産業予測、2025-2032年

Veterinary Immunodiagnostics Market Size, Share, Growth Analysis, By Product (CONSUMABLES, INSTRUMENTS), By Technology (CLINICAL BIOCHEMISTRY, Molecular Diagnostics), By Animal Type, By Disease Type, By End User, By Region - Industry Forecast 2025-2032


出版日
発行
SkyQuest
ページ情報
英文 165 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
動物用免疫診断薬市場規模、シェア、成長分析、製品別、技術別、動物の種類別、疾患タイプ別、エンドユーザー別、地域別 - 産業予測、2025-2032年
出版日: 2025年01月09日
発行: SkyQuest
ページ情報: 英文 165 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

動物用免疫診断薬の世界市場規模は、2023年に27億米ドルと評価され、2024年の29億2,000万米ドルから2032年には54億4,000万米ドルに成長し、予測期間(2025-2032年)のCAGRは8.1%で成長する見通しです。

動物用免疫診断薬市場は、動物疾病の蔓延、疾病特異的免疫診断検査の登場、診断技術の進歩など、いくつかの要因によって力強い成長を遂げています。ペットの飼育数の急増と動物由来食品への需要の高まりが、この拡大をさらに後押ししています。新興経済諸国は、発展途上地域においては獣医学的診断インフラが不十分ではありますが、大きな成長機会をもたらしています。現在進行中のCOVID-19パンデミックは、ヒトと動物の両方に対する検査率を高めており、検査施設は動物検査ソリューションの革新を余儀なくされています。AVMAやCDCのような組織は、動物に対するルーチンのCOVID-19検査を推奨していませんが、進展する状況に基づいて保健当局が決定を下すこともあり、獣医師と保健当局の協力の重要性が浮き彫りになっています。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次データと一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2024年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析

動物用免疫診断薬市場規模:製品別

  • 市場概要
  • 消耗品
  • 機器

動物用免疫診断薬市場規模:技術別

  • 市場概要
  • 臨床生化学
  • 臨床化学分析
  • 臨床化学試薬クリップとカートリッジ
  • 臨床化学分析装置
  • 血糖モニタリング
    • 血糖値試験紙
    • 血糖値モニター
    • 尿糖試験紙
    • 血液ガスおよび電解質分析
  • 血液ガス電解質試薬クリップカートリッジ
    • 血糖値モニター
  • 血液ガス・電解質分析装置
  • 分子診断
    • ポリメラーゼ連鎖反応(PCR)検査
    • マイクロアレイ
    • 核酸配列解析
    • その他の分子診断製品
  • 血液学
    • 血液学カートリッジ
    • 血液分析装置
  • 尿検査
    • 尿検査クリップとカートリッジ/パネル
    • 尿分析装置
    • 尿検査ストリップ
  • 免疫診断
    • ラテラルフローアッセイ
    • ラテラルフロー迅速検査
    • ラテラルフローストリップリーダー
    • ELISA検査
    • アレルゲン特異的免疫診断検査
    • 免疫測定分析装置
    • 放射免疫測定
    • その他の免疫診断製品
  • その他の獣医診断技術

動物用免疫診断薬市場規模:動物の種類別

  • 市場概要
  • コンパニオンアニマル
  • 家畜
  • 家禽
  • その他の家畜

動物用免疫診断薬市場規模:疾患タイプ別

  • 市場概要
  • 感染症
  • 細菌感染
  • ウイルス感染
  • 寄生虫感染
  • その他の感染症
  • 内分泌器
  • 腫瘍
  • 心臓病
  • その他

動物用免疫診断薬市場規模:エンドユーザー別

  • 市場概要
  • 獣医学リファレンスラボラトリー
  • 動物病院・クリニック
  • ポイントオブケア/インハウス検査
  • 獣医学調査機関および大学

動物用免疫診断薬市場規模

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2024年)
  • 主な市場企業が採用した戦略
  • 市場の最近の動向
  • 企業の市場シェア分析(2024年)
  • 主要企業の企業プロファイル
    • 会社概要
    • 製品ポートフォリオ分析
    • セグメント別シェア分析
    • 収益の前年比比較(2022-2024)

主要企業プロファイル

  • IDEXX Laboratories, Inc.(USA)
  • Zoetis Inc.(USA)
  • Thermo Fisher Scientific Inc.(USA)
  • bioMerieux SA(France)
  • Heska Corporation(USA)
  • NEOGEN Corporation(USA)
  • Bio-Rad Laboratories, Inc.(USA)
  • Virbac(France)
  • FUJIFILM Holdings Corporation(Japan)
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.(China)
  • INDICAL BIOSCIENCE GmbH(Germany)
  • BioNote, Inc.(South Korea)
  • Biogal Galed Labs(Israel)
  • Agrolabo S.p.A.(Italy)
  • IDvet(France)
  • Randox Laboratories Ltd.(UK)
  • BioChek(Netherlands)
  • Biopanda Reagents(UK)
  • URIT Medical Electronic Co., Ltd.(China)
  • Bionote, Inc.(South Korea)

結論と推奨事項

目次
Product Code: SQMIG35I2291

Global Veterinary Immunodiagnostics Market size was valued at USD 2.7 billion in 2023 and is poised to grow from USD 2.92 billion in 2024 to USD 5.44 billion by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

The veterinary immunodiagnostics market is experiencing robust growth driven by several factors, including the increased prevalence of animal diseases, the advent of disease-specific immunodiagnostic tests, and advancements in diagnostic technology. A surge in pet ownership and rising demand for animal-derived food products further fuel this expansion. Emerging economies present significant growth opportunities, despite challenges posed by inadequate veterinary diagnostic infrastructure in developing regions. The ongoing COVID-19 pandemic has heightened testing rates for both humans and animals, compelling laboratories to innovate animal testing solutions. Although organizations like the AVMA and CDC do not endorse routine COVID-19 testing for animals, the decision may be prompted by health officials based on evolving circumstances, underscoring the importance of collaboration between veterinarians and health authorities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Veterinary Immunodiagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Veterinary Immunodiagnostics Market Segmental Analysis

Global Veterinary Immunodiagnostics Market is segmented by Product, Technology, Animal Type, Disease Type, End User and region. Based on Product, the market is segmented into Consumables and Instruments. Based on Technology, the market is segmented into Clinical Biochemistry, Molecular Diagnostics, Hematology, Urinalysis, Immunodiagnostics and Other Veterinary Diagnostic Technologies. Based on Animal Type, the market is segmented into Companion Animals and Livestock. Based on Disease Type, the market is segmented into Infectious Disease, Endocrinology, Oncology, Cardiology and Others. Based on End User, the market is segmented into Veterinary Reference Laboratories, Veterinary Hospitals & Clinics, Point-of-care/ In-house Testing and Veterinary Research Institutes & Universities. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Veterinary Immunodiagnostics Market

The Global Veterinary Immunodiagnostics market is significantly driven by the potential transmission of serious zoonotic illnesses from animals to humans. At least 30 major diseases, including rabies, leptospirosis, and zoonotic tuberculosis, can spread through livestock and companion animals such as dogs and cats. The increasing prevalence of transboundary diseases, exemplified by foot-and-mouth disease affecting a large portion of livestock globally, further underscores the need for effective immunodiagnostic tools. Additionally, the emergence of zoonotic sources such as those linked to the COVID-19 pandemic highlights the critical role veterinary diagnostics play in safeguarding public health and preventing future outbreaks, ultimately fostering market growth.

Restraints in the Global Veterinary Immunodiagnostics Market

The Global Veterinary Immunodiagnostics market faces significant restraints due to the rising costs associated with pet care over the last decade. Research indicates that veterinary care represents the second-largest spending category within the pet care industry, with the U.S. alone contributing over $18.11 billion, marking a 6.1% increase from the previous year. High-end veterinary procedures can range from $5,000 to $20,000, while typical diagnostic costs for assessing antimicrobial resistance or infections using advanced techniques like PCR are notably steep. The reliance on expensive materials and cutting-edge technologies for treatments makes pet owners and veterinarians reluctant to invest heavily in diagnostic services.

Market Trends of the Global Veterinary Immunodiagnostics Market

The Global Veterinary Immunodiagnostics market is poised for significant growth, driven by the rising prevalence of zoonotic and vector-borne diseases linked to climate change, habitat modification, and evolving social dynamics. As these diseases become more common, there is an increasing need for rapid and precise diagnostic tools, particularly in companion animal medicine in developed countries. This trend is further fueled by a growing preference for advanced diagnostic technologies, such as RT-PCR, over traditional methods. Consequently, veterinary immunodiagnostics will play a critical role in disease management and prevention, positioning itself as a vital segment within the broader veterinary diagnostics market.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Veterinary Immunodiagnostics Market Size by Product & CAGR (2025-2032)

  • Market Overview
  • Consumables
  • Instruments

Global Veterinary Immunodiagnostics Market Size by Technology & CAGR (2025-2032)

  • Market Overview
  • Clinical Biochemistry
  • Clinical Chemistry Analysis
  • Clinical Chemistry Reagent Clips & Cartridges
  • Clinical Chemistry Analyzers
  • Glucose Monitoring
    • Blood Glucose Strips
    • Glucose Monitors
    • Urine Glucose Strips
    • Blood Gas & Electrolyte Analysis
  • Blood Gas And Electrolyte Reagent Clips and Cartridges
    • Glucose Monitors
  • Blood Gas & Electrolyte Analyzers
  • Molecular Diagnostics
    • Ploymerase Chain Reaction (PCR) Tests
    • Microarrays
    • Nucleic Acid Sequencing
    • Other Molecular Diagnostic Products
  • Hematology
    • Hematology Cartridges
    • Hematology Analyzers
  • Urinalysis
    • Urinalysis Clips & Cartridges/Panels
    • Urine Analyzers
    • Urine Test Strips
  • immunodiagnostics
    • Lateral Flow Assays
    • Lateral Flow Rapid Tests
    • Lateral Flow Strip Readers
    • ELISA Tests
    • Allergen-specific Immunodiagnostic Tests
    • Immunoassay Analyzers
    • Radioimmunoassay
    • Other Immunodiagnostic Products
  • Other Veterinary Diagnostic Technologies

Global Veterinary Immunodiagnostics Market Size by Animal Type & CAGR (2025-2032)

  • Market Overview
  • Companion Animals
  • Dogs
  • Cats
  • Horses
    • Other Companion Animals
  • Livestock
  • Cattle
  • Pigs
  • Poultry
  • Other Livestock

Global Veterinary Immunodiagnostics Market Size by Disease Type & CAGR (2025-2032)

  • Market Overview
  • Infectious Disease
  • Bacterial Infection
  • Viral Infection
  • Parasitic Infection
  • Other Infection
  • Endocrinology
  • Oncology
  • Cardiology
  • Others

Global Veterinary Immunodiagnostics Market Size by End User & CAGR (2025-2032)

  • Market Overview
  • Veterinary Reference Laboratories
  • Veterinary Hospitals & Clinics
  • Point-of-care/ In-house Testing
  • Veterinary Research Institutes & Universities

Global Veterinary Immunodiagnostics Market Size & CAGR (2025-2032)

  • North America (Product, Technology, Animal Type, Disease Type, End User)
    • US
    • Canada
  • Europe (Product, Technology, Animal Type, Disease Type, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product, Technology, Animal Type, Disease Type, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product, Technology, Animal Type, Disease Type, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, Technology, Animal Type, Disease Type, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • IDEXX Laboratories, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zoetis Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • bioMerieux SA (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Heska Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NEOGEN Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Virbac (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • FUJIFILM Holdings Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • INDICAL BIOSCIENCE GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BioNote, Inc. (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biogal Galed Labs (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agrolabo S.p.A. (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • IDvet (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Randox Laboratories Ltd. (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BioChek (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biopanda Reagents (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • URIT Medical Electronic Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bionote, Inc. (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations